BioMarin Pharmaceutical (NASDAQ:BMRN) Receives Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a report issued on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a $110.00 target price on the biotechnology company’s stock. Cantor Fitzgerald also issued estimates for BioMarin Pharmaceutical’s FY2024 earnings at $2.05 EPS. BMRN has been the topic […]
More Stories
iShares Core S&P Small-Cap ETF (NYSEARCA:IJR) Shares Acquired by Bartlett & CO. Wealth Management LLC
Bartlett & CO. Wealth Management LLC lifted its holdings in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free...
UniBot (UNIBOT) Trading Down 6.2% Over Last Week
UniBot (UNIBOT) traded down 1.4% against the US dollar during the one day period ending at 20:00 PM E.T. on...
iShares Core S&P Small-Cap ETF (NYSEARCA:IJR) Shares Purchased by IFG Advisors LLC
IFG Advisors LLC lifted its position in iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by 5.4% in the...
ZEON Hits 24 Hour Trading Volume of $9,891.76 (ZEON)
ZEON (ZEON) traded 2.5% higher against the US dollar during the 1-day period ending at 20:00 PM Eastern on October...
Stargate Finance Price Hits $0.30 on Top Exchanges (STG)
Stargate Finance (STG) traded 0.4% lower against the US dollar during the 1 day period ending at 20:00 PM E.T....
Numeraire (NMR) One Day Volume Tops $2.73 Million
Numeraire (NMR) traded up 0.1% against the US dollar during the 24 hour period ending at 20:00 PM ET on...